Dr. van Besien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-553-2797- Is this information wrong?
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1990- Indiana University School of MedicineResidency, Internal Medicine, 1987 - 1989
Catholic University of LeuvenClass of 1984
Certifications & Licensure
OH State Medical License 2022 - 2026
NY State Medical License 2011 - 2025
IL State Medical License 1997 - 2014
TX State Medical License 1992 - 2001- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsMulticenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sig...> ;Blood. 2023 May 4
- Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, Zhengming Chen, Joanna G Escalon, Alan C Legasto, Geraldine Brusca-Augello, Samuel Yamshon, Markus Plate, Dana ...> ;Transplantation and Cellular Therapy. 2023 May 1
- 3 citationsPre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga, Tsiporah B Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A Phi...> ;Transplantation and Cellular Therapy. 2023 Feb 1
- Join now to see all
Abstracts/Posters
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain AmyloidosisKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple MyelomaKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Other Languages
- Spanish, French, German, Dutch
Hospital Affiliations
University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
